An Open-Label, Single-Center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer
This study is currently recruiting participants.
Study NCT00561197
Information provided by Ascenta Therapeutics
First Received: November 19, 2007
Last Updated: January 8, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
